1. Introduction {#s0005}
===============

Lung cancer is one of the main reasons for cancer-related mortalities world-wide ([@b0335]). The association of *Chlamydia pneumonia (C. pneumonia)* infections with lung cancer etiology has been previously suggested ([@b0040], [@b0240]). However, the process of carcinogenesis is not well understood yet. *C. pneumoniae* is a widespread intracellular respiratory bacterium that needs host cell for their existence and multiplication within host cells. It has evolved various effector proteins and toxins that interfere with cell death signalling pathways in host cells and the machinery of cell death executioner ([@b0025]). Nucleus, mitochondria, and cytoplasm are critical components for normal host-cell functions ([@b0020], [@b0135]). Mitochondria, which are generally considered to originate from endosymbiotic event, plays an important role in numerous biochemical cascades that direct to programmed cell death ([@b0120]). Therefore, investigating the mechanisms by which intracellular pathogens such as *C. pneumoniae* may alter apoptotic pathways is of special interest.

We have recently studied the nuclear targeting of *C. pneumoniae* proteins through computational approach during intracellular infection where they may play crucial role in progress and development of lung cancer ([@b0170]). Nevertheless, the fact that many *C. pneumoniae* proteins are targeted into mitochondria, cytoplasm, and other host intracellular components may alter many biochemical pathways in the host. Here we systematically predict several *C. pneumoniae* proteins that can localize into host mitochondria and cytoplasm where they can influence the development and progress of lung cancer.

2. Materials and methods {#s0010}
========================

2.1. Protein database for the selection of *C. pneumoniae* strain {#s0015}
-----------------------------------------------------------------

The Uniprot database was screened out for the selection of *C. pneumoniae* strain. Five strains *C. pneumoniae* are publicly accessible in Uniprot database with different number of proteins ([@b0155], [@b0270], [@b0285], [@b0330]). The *C. pneumoniae* pathogen is reported as obligate gram negative bacteria which may act as a potential factor of lung cancer ([@b0390], [@b0400]).

2.2. cNLS mapper for the analysis of NLS {#s0020}
----------------------------------------

The bioinformatics software cNLS mapper was utilized for the analysis of nuclear localization signal (NLS) in whole proteins of *C. pneumoniae* TW-183 strain ([@b0215]). The whole sequence of all proteins was utilized for the analysis of monopartite and bipartite NLS sequence cutoff value.

2.3. BaCelLo for the analysis of sub cellular protein targeting in different cell compartments {#s0025}
----------------------------------------------------------------------------------------------

Protein targeting of *C. pneumoniae* TW-183 stain in different eukaryotic cell organelles were analysed by bioinformatics software Balanced Sub Cellular Localization predictor (BaCeILo). The BaCelLo software based on three well known datasets for eukaryotic kingdoms which includes plants, fungi, and animals ([@b0275]). The software analyses the five different classes of sub cellular localization such as mitochondrial, cytoplasmic, nuclear, chloroplast and secretory. The current study was performed with animal datasheet related tool.

3. Results {#s0030}
==========

3.1. Protein database for the selection of *C. pneumoniae* strain {#s0035}
-----------------------------------------------------------------

Whole proteins of *C. pneumoniae* (TW-183 strain) were analysed in present study. We selected *C. pneumoniae* TW-183 strain for our prediction study because of its contains the largest proteome, total of 1112 proteins, as compared to the other four *C. pneumoniae* strains J138, CWL029, AR39 and LPCoLN ([@b0155], [@b0270], [@b0285], [@b0330]). Scheme showed the summary of work plan for data analysis and possible outcome. Detailed description was presented in the experimental, result and discussion section ([Fig. 1](#f0005){ref-type="fig"}).Fig. 1Scheme illustrated the summary of work plan in current study during data prediction and analysis.

3.2. Prediction of mitochondrial targeting of *C. pneumoniae* proteins {#s0040}
----------------------------------------------------------------------

The prediction results of BaCeILo have shown 183 proteins target to host cell mitochondria out of total 1112 proteins. It was found that raising bipartite NLS cutoff value of proteins was associated with high probability to targeting in mitochondria. On the contrary, an opposite pattern was noticed with monopartite NLS value of predicted proteins ([Table 1](#t0005){ref-type="table"}). However, no correct connection was predicted with molecular weight and protein targeting to mitochondrial except in few cases where the proteins with minimum molecular weight (0--20 kDa) were mainly localized in host-cell mitochondria ([Table 2](#t0010){ref-type="table"}). The results of pI values were not indicating any constant pattern for targeting of *C. pneumonia* proteins in host mitochondria ([Table 3](#t0015){ref-type="table"}). Multi-modality of pI distribution is a common feature in different whole proteomes. Some researchers studied pI value corelate to the protein localization in different subcellular compartments ([@b0375]). The outlines of proteins localization in host mitochondria illustrated in [Fig. 2](#f0010){ref-type="fig"}. Furthermore, as shown in ([Table S1](#s0070){ref-type="sec"}), we have provided details about 183 proteins predicted to target mitochondria during our study.Table 1Computational prediction of *Chlamydia pneumoniae* proteins targeting to mitochondria and cytoplasm of host cell and their relation with total proteins with similar NLS.NLSNLS Cutoff valuesNumber of proteins targeting mitochondriaTotal number of proteins in this rangePercentageNLS Cutoff valuesNumber of proteins targeting cytoplasmTotal number of proteins in this rangePercentageMonopartite NLS0--3.015198115.390--3.046598147.403.0--5.0136420.313.0--5.0226434.275.0--8.01650325.0--8.0175034\>8.031717.64\>8.0091752.94Bipartite NLS0--3.0242748.750--3.010827439.413.0--5.010961617.693.0--5.030561649.515.0--8.04820922.965.0--8.09320944.49\>8.021315.38\>8.0071353.84Table 2Computational prediction of *Chlamydia pneumoniae* proteins targeting to mitochondria and cytoplasm of host cell and their relation with total proteins with similar molecular weight.Molecular weightNumber of proteins targeting to mitochondriaTotal number of proteinsPercentageMolecular weightNumber of proteins targeting to cytoplasmTotal number of proteinsPercentage0--20 kD6532619.930--20 kD10232631.2820--40 kD6738417.4420--40 kD19138449.7340--60 kD3623515.3140--60 kD12623553.6160--80 kD108711.4960--80 kD568764.36\>80 kD5806.25\>80 kD388047.50Table 3Computational prediction of *Chlamydia pneumoniae* proteins targeting to mitochondria and cytoplasm of host cell, and their relation with total proteins with similar pI value.Range of pI valueNumber of proteins targeting to mitochondriaTotal number of proteinsPercentageRange of pI valueNumber of proteins targeting to cytoplasmTotal number of proteinsPercentage3.0--5.041063.773.0--5.0581064.715.0--6.0222977.405.0--6.018729762.966.0--7.02017511.426.0--7.09617554.857.0--8.0107912.657.0--8.0387948.108.0--9.024150168.0--9.05915029.339.0--106121528.379.0--105221524.1810.0--11.0307042.8510.0--11.0177024.2811.0--13.012206011.0--13.062030Fig. 2*C. pneumoniae* targeting proteins in host mictochondria as per different range of monopartite NLS cut-off value (a), bipartite NLS cut-off value (b), molecular weight (c), and pI value (d).

3.3. Prediction of cytoplasmic targeting of *C. pneumoniae* proteins {#s0045}
--------------------------------------------------------------------

The prediction results of BaCeILo have shown 513 proteins targeted to host cell cytoplasm out of total 1112 proteins of whole *C. pneumoniae* proteome. Most of the proteins containing NLS cutoff value of 3--5 were targeted to the cytoplasm with respect to monopartite NLS and bipartite NLS cutoff values ([Table 1](#t0005){ref-type="table"}). Also, most proteins with higher molecular weights were associated host-cell cytoplasmic localization with few exceptions ([Table 2](#t0010){ref-type="table"}). On the other hand, it was observed that the increasing the pI value of the predicted proteins constantly decreased the localization in cytoplasm of host cell ([Table 3](#t0015){ref-type="table"}). The localization patterns of *C. pneumoniae* proteins in host cytoplasm are illustrated in [Fig. 3](#f0015){ref-type="fig"} with different parameters. Moreover, additional data provides the description regarding various *C. pneumoniae* proteins targeting to cytoplasm of host cell are listed in ([Table S2](#s0070){ref-type="sec"}).Fig. 3*C. pneumoniae* targeting proteins in host cytoplasm as per different range of monopartite NLS cut-off value (a), bipartite NLS cut-off value (b), molecular weight (c), and pI value (d).

4. Discussion {#s0050}
=============

Various bacterial proteins modulate host cell survival leading to dynamical suppression of host cell death as a mean for bacterial persistence and multiplication ([@b0085], [@b0090], [@b0280], [@b0005]. *In silico* analysis of protein subcellular localization can significantly help to explain bacterial-protein potential functions. Although many advanced experimental high-throughput approaches have been developed to determine proteins localization, they are time consuming and cost ineffective ([@b0145], [@b0175], [@b0180], [@b0245], [@b0265]). In the advancement of bioinformatics, fast and highly-accurate genome-scale computational predictors of subcellular protein targeting/localization offer a good complement for experimental practice ([@b0100], [@b0290]). cNLS Mapper predicts classical NLS functionality of proteins by analysing summation of the functional role of each amino acid in the query protein as per the activity-based profiles, which are achieved from the systematic residue-replacement analyses in *Saccharomyces cerevisiae*. Although analysis of NLS in a particular sequence of protein is essential for analysing its nuclear localization with the highest cNLS score, the cNLS Mapper is a predictor to analyse NLS activity rather than NLS sequence as it consequently predicts cytoplasmic localization of proteins ([@b0130], [@b0215], [@b0220]).

In contrast, BaCelLo is another predictor that utilizes a decision tree which was developed on diverse SVMs for the prediction of nuclear, mitochondrial, chloroplast, and cytoplasmic targeting of particular proteins ([@b0275]). Also, BaCelLo predicts complete protein sequence along with its N and C termini and analyse the results on the basis of information gained by amino acid residue sequence and evolutionary alignment. To impede different mitochondrial functions, bacterial proteins should attach to- and enter the mitochondria during the course of infection ([@b0065], [@b0225]). In addition to several anomalous mitochondrial functions, cancer cells have impaired oxidative phosphorylation as a result of the high-rate modified glycolysis with elevated fermentation of lactic acid, which permits cancer cells to retain biosynthetic fluxes at the time of fast proliferation ([@b0075], [@b0295], [@b0360]). Nevertheless, cancer cells showed antagonistic properties towards mitochondria-mediated apoptotic pathways ([@b0305], [@b0360]). In the current *in silico* analysis, we predicted a sum of 183 proteins out of total 1112 proteins of *C. pneumoniae* targets to host-cell mitochondria, which may alter mitochondrial functions to the favour of oncogenesis.

We analysed bacterial DNA-binding protein HU due to its potential of influencing mitochondrial protein expression. As they share properties with histone proteins, the potential involvement of DNA-binding proteins in the growth and progression of cancer have been revealed in various studies. Methyl CpG binding protein has the potential to interfere with methylation of target DNA and involved as a crucial factor for the progression of cancer ([@b0005], [@b0110]). Chromodomain helicase DNA binding protein 1-like (CHD1L) plays a critical role in pathogenesis of hepatocellular carcinoma ([@b0055], [@b0250]). Similarly, Chromodomain helicase DNA binding protein 5 (CHD5) is an effective tumor repressor that potentially engaged in the growth of lung cancer due to their function inactivation by epigenetic mechanism ([@b0340], [@b0420]). In general, bacterial DNA-binding proteins may interfere with ability of host DNA-binding proteins to interact with host DNA. It has been observed that over expression of inhibitor of DNA-binding protein (ID1) and vascular endothelial growth factor (VEGF) is associated with the growth and progression of various type of cancer ([@b0105], [@b0235], [@b0125]). Moreover, our findings show that many gene expression regulators can target host mitochondria. These proteins include, but are not limited to, transcription initiation factor sigma D protein (Q9Z8I1), transcription repressor protein HrcA (Q9Z850), endonuclease IV (Q9Z7H3), tRNA-ribosyltransferase (Q9Z8W5), DNA-directed DNA polymerase III chain (Q7VQ53), Methionyl-tRNA formyltransferase (Q9Z7Q5), DNA repair protein RecO (Q9Z7W5), Ribonuclease H-III (Q9Z6J1), ribosome-binding factor A (Q9Z8M0), RNA methyltransferase (Q9Z7N0), endonuclease III (Q9Z769), translation initiation factor IF-3 (Q9Z6R9).

Mitochondria have their own genetic material and protein-synthesizing machinery, which more closely resembles bacteria. It has been examined in a study that bacterial RNA polymerase have the capability to act upon host DNA sequences due to conserved nature of RNA polymerase II and bacterial RNA polymerases ([@b0165], [@b0265]). Another study illustrated conserved mechanisms for substrate binding and nucleotide integration with bacteriophage RNA polymerase ([@b0195], [@b0320]). Similarly, the possible function of transcription termination proteins of *C. pneumoniae* on human transcription termination genes should be examined prior to any conclusion. Although enormous difference is observed among the mechanisms of transcription termination in human and bacterial cells, it is found plausible that many RNA polymerase II transcribed genes of eukaryotes use attenuation and antitermination processes as same as bacteria ([@b0030]). Therefore, we predicted the localization of transcription termination associated factor IF-3 and DNA-directed DNA polymerase III chain in host mitochondria.

Moreover, the DNA-binding proteins we predicted may also interfere with other existing mitochondrial gene regulation proteins in host cells through binding with particular sequences as they may alter the expression level of various genes. Many reports revealed that alteration in the replication and/or expression of mitochondria is connected with progression of many type of cancer including lung cancer ([@b0115], [@b0325], [@b0365], [@b0355]). Mutations in the mitochondrial DNA (mtDNA) have long been supposed to play a crucial role in cancer etiology including lung cancer ([@b0035]). Earlier reports showed that approximately 43% of lung cancers had mtDNA mutations ([@b0095]). The mtDNA is more common for mutations because of reduced fidelity of DNA polymerase of mitochondria, increased level of generation of endogenous ROS, and lack of effective repair mechanisms for mtDNA ([@b0260]). Although our results revealed the potential of various *C. pneumoniae* proteins to enter host mitochondria and create mutation in host mtDNA and subsequently alter gene expression, the limited information of *in silico* studies required accurate experimental support prior to conclusion. Furthermore results with other proteins are illustrated in [Table S1](#s0070){ref-type="sec"}.

The metabolism of cancer cell characterized by elevated rate of glycolysis in presence of oxygen ([@b0210]). This event, noticed by O. Warburg in 1924 and believed as the result of a "damaged" metabolism ([@b0370]). Our results indicated that *C. pneumoniae* enzymes glyceraldehyde 3 phosphate dehydrogenase (GAPDH, Accession no. Q9Z7T0) and acetyltransferase (Accession no. Q9Z7X8) localize to host mitochondria. Same enzymes from diverse species may exert enormous effect on particular substrates. This phenomenon is highly liable with an enzyme or protein from two distant evolutionary progenitors such as *C. pneumoniae* and human. Deregulation in glycolysis due to dysfunction of GAPDH has been associated with declined apoptotic signals in several types of cancer including lung cancer ([@b0010], [@b0230], [@b0345]). Similarly, dysfunction of acetyltransferase was associated with lung cancer etiology ([@b0415]). Other *C. pneumoniae* enzymes such as endonuclease III and IV are also potentially target host cell mitochondria. Endonuclease III and IV have homology with human NTH1 and APE1 respectively ([@b0140], [@b0255]). Up regulation in the expression of mitochondrial NTH1 and APE-1 is a characteristic for many type of cancers included lung cancer ([@b0160], [@b0395]). Therefore, experimental evidence should be evaluated on the basis of such prediction.

Similarly, cytoplasmic localization of *C. pneumoniae* proteins host cell may exert several effects which may lead to oncogenesis. Our study predicted a variety of *C. pneumoniae* proteins localized to cytoplasm of host cell as indicated in ([Table S2](#s0070){ref-type="sec"}). Among which, some proteins may alter the normal functioning of mRNA, tRNA, ribosome, translation, nucleotide synthesis and nucleotide degradation. We explored the cytoplasmic localization of some *C. pneumoniae* enzymes including aspartyl-tRNA synthetase (Q9Z7P2) and uridylate kinases (Q9Z7K7). The enzyme aspartyl-tRNA synthetase is a part of aminoacyl-tRNA synthetases (ARSs) multi-enzyme complex, which is involved in protein synthesis. It is reported that twenty types of ARSs connect each amino acid to their related tRNAs. Particular ARSs are linked with various diseases condition including autoimmune diseases, neuronal diseases, and cancer ([@b0185], [@b0190]). Moreover, altered level of expression of uridylate kinases (Q9Z7K7), which is involved in the pryimeden nucleoside biosynthesis, was associated with multiple types of cancer ([@b0150], [@b0385]).

Several studies confirmed the involvement of various types of proteases in cancer progression through influencing angiogenesis cell adhesion, migration and proliferation ([@b0070], [@b0205]). We analysed ATP-dependent Clp protease (Q9Z760), methionine aminopeptidase (Q9Z6Q0), ATP-dependent zinc metalloprotease (Q9Z6R1), and ATP-dependent protease La (Q9Z9F4). These enzymes are involved in peptide and abnormal protein degradation. In addition to proteases, methyltransferases, enzymes that catalyse site-specific methylation, are associated with various types of oncogenesis ([@b0060]). We investigated host-cell cytoplasmic localization of *C. pneumoniae* protoporphyrinogen oxidase (Q7VQ81), DNA methyltransferase (Q9Z7V8), tRNA (guanine-N(7)-)-methyltransferase (Q9Z6S3), and SAM dependent methyltransferase (Q9Z821) cytidine/uridine-2′-O-)-methyltransferase (Q9Z7P4). The inactivation of protoporphyrinogen oxidase is associated with liver cancer in acute porphyries ([@b0315]). Similarly, DNA methyltransferases performed the process of methylation and a potential targets for cancer therapy ([@b0110]). Moreover, ADP/ATP carrier protein 2 (Q9Z7U0) predicted in cytoplasmic localization, which act as a decisive component in apoptosis and demonstrated recently to have an important role in cancer ([@b0055]). In addition, nucleoside diphosphate kinase (NDK) (Q9Z7T5), is also analysed to localize in the cytoplasm of host cell. NDK is involved in cell growth differentiation, proliferation, and tumor metastasis. Furthermore, it is also important for the metabolism and synthesis of nucleotide. The presence of enzyme NDK in host cytoplasm has been implicated in cancer etiology ([@b0200]). Nevertheless the exact role of NDK in cancer needs further appraisal. Thus, it might be possible that the expected future of a cell is dictated by various factors of host and microbiota, including bacteria, in order to transform a normal cell into cancerous cell.

Translation is a very important process to control the normal expression of several proteins. The possible involvement of translation-associated proteins in growth and advancement of cancer was examined and confirmed in numerous studies ([@b0015], [@b0300]). In our study, various ribosomal proteins of *C. pneumoniae* were predicted to localize in cytoplasm of host cell, which also acts as RNA-binding proteins. For instant, 30S ribosomal protein S1 (Q9Z8M3), S6 (Q9Z6V5), S5 (Q9Z7S3), and S20 (Q9Z7F2) are needed to express the mRNA with Shine--Dalgarno sequence. Similarly, various 50S ribosomal proteins are predicted in our study including L10 (Q9Z9A2), L9 (Q9Z6V3), L4 (Q9Z7Q8), L5 (Q9Z7R9), L29 (Q9Z7R5), L27 (Q9Z807), L33 (Q9Z8T4), L34 (Q9Z6X1) and L35 (Q9Z6R8), L36 (Q9Z6X0), which potentially involved in various steps of translation and ribosome biogenesis in *C. pneumoniae*. Control of translation is a critical component for the progress and advancement of cancer ([@b0015], [@b0340]). It was reported that hyper-activated signalling pathways potentially manipulate the translation, which may be permitting of uncontrolled growth of cells ([@b0125]). The cytoplasmic localization of *C. pneumoniae* enzymes and protein, which were observed in our study, showed the capability to interact with various regulatory elements and RNA of the host. Several RNA-binding proteins were shown to play a significant role in cancer development through regulation of gene expression at the post-transcriptional level ([@b0125], [@b0165]). Many recent studies reported the involvement of various RNA-binding enzymes in cancer progression ([@b0350], [@b0380]).

A category of enzymes are ribonucleases that cleave the phosphodiester bond of RNA and directing to many types of cellular consequences in host cell. It is evident that mammalian ribonucleases are involved in both prevention and development of various types of cancer ([@b0195]). Nevertheless, the possible involvement of bacterial ribonucleases during their infection in oncogenesis is not much identified and requires precise biological corroborations. In our study, various ribonucleases such as ribonuclease III (Q9Z9C7), ribonuclease Z (Q9Z9F6), ribonuclease G (Q9Z6U9), and ribonuclease HII (Q9Z962) were analysed to localize in cytoplasm of host cell. Ribonuclease III (Q9Z9C7) is involved in processing mRNA, rRNA, and tRNA, whereas ribonuclease Z (Q9Z9F6) is involved in 3′-tRNA processing activity. In addition, ribonuclease HII (Q9Z962) and ribonuclease G (Q9Z6U9) are showing RNA-DNA hybrid ribonuclease activity in *C. pneumoniae*. Hence, ribonuclease-activated prodrugs emerged as a new line of investigation ([@b0080]). GTPase HflX (Q7VQ01) is another RNA-binding protein predicted in our study. GTPase have the ability to hydrolyse the GTP and potentially involved in infection-induced oncogenesis ([@b0355]). Nevertheless, further more suitable experimental validation for *C. pneumoniae* cytoplasmic localization in human and their potential role in lung cancer etiology.

Altered level of expression of heat shock proteins (HSP) in different types of cancer have been investigated in several studies ([@b0045], [@b0050]). Here, we predicted the cytoplasmic localization of various conserved HSP including HSP-70 (P27542), 60 kDa chaperonin (GroEL protein) (P31681), and Protein GrpE (HSP-70 cofactor) (Q9Z849), which may be engaged in accurate protein folding during adverse conditions in *C. pneumoniae*. For instant, Hsp70 shares about 50% sequence identity between *C. pneumoniae* and human whereas many domains showed 96% identities ([@b0310], [@b0425]). It has been revealed in several reports that bacterial HSPs helps in protection of epithelial cells from apoptosis and may enhance the process of cell proliferation ([@b0405], [@b0410]). The involvement of bacterial HSPs in proliferation of cell and cytoplasmic targeting of *C. pneumoniae* HSPs in lung cells during infection enhance the possible risk of lung cancer. This potential association between *C. pneumoniae* infection and risk of lung cancer gained credibility in the past many years but no consensus has been reached.

5. Conclusion {#s0055}
=============

Taken together, our current prediction results show that *C. pneumoniae* protein targeting host-cell mitochondria and cytoplasm may act as a potential factor for growth and development of lung cancer. We hypothesize that alteration in normal functioning of cells may induced the process of carcinogenesis due to host-pathogen protein-protein interaction through dysregulation in various pathways of mitochondria and cytoplasm with different strategies. Although the present research suggests explanations of the role of *C. pneumoniae* in the progress and advancement of lung cancer, experimental research are urgently needed to confirm and validate the *in-silico* results. These findings should open new avenues for clinical microbiologists and oncologists when dealing with *C. pneumoniae* infections.
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